GDNF/GFRA1 signaling contributes to chemo- and radioresistance in glioblastoma.

Sci Rep · 2024 · PMC11292001 · PMID 39085346

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

Only the T87 KO2 10% decrease in post-treatment viability was borderline significant when compared to the NTC1 control, with a p -value of 0.06.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.